Search Results - "Warnke, C."

Refine Results
  1. 1
  2. 2

    Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis by Schweitzer, F., Laurent, S., Fink, G. R., Barnett, Michael H., Hartung, H. P., Warnke, C.

    Published in Journal of neurology (01-07-2021)
    “…Modern disease-modifying therapies (DMTs) in multiple sclerosis (MS) have variable modes of action and selectively suppress or modulate the immune system. In…”
    Get full text
    Journal Article
  3. 3

    Cognitive outcomes in patients with essential tremor treated with deep brain stimulation: a systematic review by Al Ali, Jamal, Lacy, Maureen, Padmanaban, Mahesh, Abou Chaar, Widad, Hagy, Hannah, Warnke, Peter C, Xie, Tao

    Published in Frontiers in human neuroscience (02-02-2024)
    “…Essential tremor (ET) is a common neurological disease. Deep brain stimulation (DBS) to the thalamic ventral intermediate nucleus (VIM) or the adjacent…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Deep Brain Stimulation Impedance Decreases Over Time Even When Stimulation Settings Are Held Constant by Satzer, David, Yu, Huiyan, Wells, Meredith, Padmanaban, Mahesh, Burns, Matthew R., Warnke, Peter C., Xie, Tao

    Published in Frontiers in human neuroscience (09-11-2020)
    “…Objectives: To study whether and to what extent the therapeutic impedance and current change under long-term deep brain stimulation (DBS) with constant…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Case series analysis, meta-analysis or no analysis in the evaluation of neurosurgical techniques: get better or get out by Warnke, Peter C

    “…Schumpeter's principle of creative destruction which describes how new products and processes will render older ones obsolete is in full swing here. 4 As to…”
    Get full text
    Journal Article
  8. 8

    SEEG in 3D: Interictal Source Localization From Intracerebral Recordings by Satzer, David, Esengul, Yasar T, Warnke, Peter C, Issa, Naoum P, Nordli, Jr, Douglas R

    Published in Frontiers in neurology (08-02-2022)
    “…Stereo-electroencephalography (SEEG) uses a three-dimensional configuration of depth electrodes to localize epileptiform activity, but traditional analysis of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Selective peripheral denervation for cervical dystonia: a historical procedure in the age of deep brain stimulation? by Warnke, PC

    “…Significant therapeutic benefit was achieved on the Tsui dystonia scale, the visual analogue scale for pain and the Fugl-Meyer quality of life scale, which was…”
    Get full text
    Journal Article
  11. 11

    Changes to anti-JCV antibody levels in a Swedish national MS cohort by Warnke, Clemens, Ramanujam, Ryan, Plavina, Tatiana, Bergström, Tomas, Goelz, Susan, Subramanyam, Meena, Kockum, Ingrid, Rahbar, Afsar, Kieseier, Bernd C, Holmén, Carolina, Olsson, Tomas, Hillert, Jan, Fogdell-Hahn, Anna

    “…Background The anti-JC virus (JCV) antibody status has been introduced to stratify patients with multiple sclerosis (MS) for higher or lower risk of…”
    Get full text
    Journal Article
  12. 12

    Surgical Outcomes and EEG Prognostic Factors After Stereotactic Laser Amygdalohippocampectomy for Mesial Temporal Lobe Epilepsy by Wu, Shasha, Issa, Naoum P., Lacy, Maureen, Satzer, David, Rose, Sandra L., Yang, Carina W., Collins, John M., Liu, Xi, Sun, Taixin, Towle, Vernon L., Nordli, Douglas R., Warnke, Peter C., Tao, James X.

    Published in Frontiers in neurology (17-05-2021)
    “…Objective: To assess the seizure outcomes of stereotactic laser amygdalohippocampectomy (SLAH) in consecutive patients with mesial temporal lobe epilepsy…”
    Get full text
    Journal Article
  13. 13

    German guideline for diagnosis and treatment of multiple sclerosis – a survey focusing neurologists in daily practise by Heesen, C., Mokry, C., Salmen, A., Hegen, H., Mäurer, M., Warnke, C., Gehring, K., Berthele, A., Meier, U.

    Published in Multiple sclerosis and related disorders (01-07-2022)
    “…We performed a web-based survey among German-speaking neurologists to evaluate the acceptance of the 2021 German guideline in the diagnosis and treatment of…”
    Get full text
    Journal Article
  14. 14

    The critically ill CAR T-cell patient : Relevant toxicities, their management and challenges in critical care by Garcia Borrega, J, Heindel, K, Kochanek, M, Warnke, C, Stemmler, J, von Bergwelt-Baildon, M, Liebregts, T, Böll, B

    “…CAR‑T cell therapy has been implemented as clinical routine treatment option during the last decade. Despite beneficial outcomes in many patients severe side…”
    Get full text
    Journal Article
  15. 15

    Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies by Schneider, A., Fasshauer, E., Scheiderbauer, J., Warnke, C., Köpke, S., Kasper, J., Toussaint, M., Temmes, H., Hemmer, B., Schiffmann, I., Rahn, A.C., Heesen, C.

    Published in Multiple sclerosis and related disorders (01-04-2022)
    “…Multiple sclerosis treatment options are increasing. Evidence-based patient information (EBPI) are therefore crucial to enable patient involvement in decision…”
    Get full text
    Journal Article
  16. 16

    Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis by Mokry, C, Warnke, C, Gehring, K, Hegen, H, Salmen, A, Kraemer, M, Kleiter, I, Fasshauer, E, Scheiderbauer, J, Lühmann, D, Köpke, S, Berthele, A, Heesen, C

    Published in Multiple sclerosis and related disorders (01-01-2022)
    “…•first implementation study of a clinical practice guideline in MS.•early aggressive treatment and treatment stop as major areas of controversy.•overall…”
    Get full text
    Journal Article
  17. 17

    EP 41. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathies by Stettner, M, Hinrichs, L, Guthoff, R, Bairov, S, Petropoulos, I.N, Warnke, C, Hartung, H.-P, Malik, R.A, Kieseier, B.C

    Published in Clinical neurophysiology (01-09-2016)
    “…Objective There is an unmet need for better diagnostic tools to further delineate clinical subsets of heterogeneous chronic inflammatory demyelinating…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment by Persson Berg, Linn, Eriksson, Marcus, Longhi, Sonia, Kockum, Ingrid, Warnke, Clemens, Thomsson, Elisabeth, Bäckström, Malin, Olsson, Tomas, Fogdell-Hahn, Anna, Bergström, Tomas

    Published in BMJ neurology open (27-07-2022)
    “…BackgroundPatients with multiple sclerosis (MS) demonstrate higher seroprevalence of Epstein-Barr virus (EBV) and increased anti-EBV IgG levels in serum…”
    Get full text
    Journal Article
  20. 20

    Airflow limitation, lung volumes and systemic inflammation in a general population by GLÄSER, S, ITTERMANN, T, EWERT, R, SCHÄPER, C, KOCH, B, VÖLZKE, H, WALLASCHOFSKI, H, NAUCK, M, WARNKE, C, VOGELMEIER, C, SCHULZ, H, FELIX, S. B

    Published in The European respiratory journal (2012)
    “…Although several levels of evidence have suggested an association between systemic inflammation and spirometric lung volumes, data addressing the potential…”
    Get full text
    Journal Article